Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.
The following list is consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia may not participate in every one however the list is updated regularly.
If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia at firstname.lastname@example.org or on (03) 9662 9420.
|TGA: COMPARABLE REGULATORS’ MARKETING APPROVAL
Due 30 June
|The Therapeutic Goods Administration (TGA) is seeking comments on the use of marketing approval by comparable overseas regulators for a device in an overseas market to support inclusion of the device in the Australian Register of Therapeutic Goods (ARTG). This includes proposed criteria to identify comparable overseas regulators and mechanisms to allow consideration of such overseas marketing approvals when deciding whether a medical device should be approved for the Australian market.|
|REVIEW OF ABORIGINAL AND TORRES STRAIT ISLANDER RESEARCH ETHICS GUIDELINES
Due 7 July 2017
|In 2013, NHMRC commissioned an evaluation of the following ethical guidelines:
1. Values and Ethics: Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Health Research 2003 (Values and Ethics)
2. Keeping Research on Track: A guide for Aboriginal and Torres Strait Islander peoples about health research ethics 2005 (Keeping Research on Track).
These revised guidelines are now available for public consultation.
|FRAMEWORK FOR NHMRC ASSESSMENT AND FUNDING OF CLINICAL TRIALS AND COHORT STUDIES
Due 14 July 2017
|The NHMRC is seeking comment on the proposed Framework for NHMRC Assessment and Funding of Clinical Trials and Cohort Studies.
A discussion paper has been prepared and is now available for consultation. The paper describes the challenges faced by NHMRC when funding clinical trials and cohort studies and proposes an assessment and funding framework for the future built around three key principles: the need for a strong rationale, the appropriateness of the design, and the achievement of milestones.